Given that lubiprostone is a fatty acid, it is conceivable that a mechanism involved in its proposed role in the amelioration of constipation could be of that of a ClC-2 blockade, as seen here with SCFAs, and a consequent diminution in ion absorption. The gene discussed is CLCN2; the disease is constipation disorder.